These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 25156574)

  • 1. Intravenous immunoglobulin reduces tau pathology and preserves neuroplastic gene expression in the 3xTg mouse model of Alzheimer's disease.
    Counts SE; Perez SE; He B; Mufson EJ
    Curr Alzheimer Res; 2014; 11(7):655-63. PubMed ID: 25156574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ELISA measurement of specific antibodies to phosphorylated tau in intravenous immunoglobulin products.
    Loeffler DA; Klaver AC; Coffey MP
    Int Immunopharmacol; 2015 Oct; 28(2):1108-12. PubMed ID: 26330100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous immunoglobulins for Alzheimer's disease.
    Puli L; Tanila H; Relkin N
    Curr Alzheimer Res; 2014; 11(7):626-36. PubMed ID: 25115546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for participation of aluminum in neurofibrillary tangle formation and growth in Alzheimer's disease.
    Walton JR
    J Alzheimers Dis; 2010; 22(1):65-72. PubMed ID: 20847423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human intravenous immunoglobulin provides protection against Aβ toxicity by multiple mechanisms in a mouse model of Alzheimer's disease.
    Magga J; Puli L; Pihlaja R; Kanninen K; Neulamaa S; Malm T; Härtig W; Grosche J; Goldsteins G; Tanila H; Koistinaho J; Koistinaho M
    J Neuroinflammation; 2010 Dec; 7():90. PubMed ID: 21138577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Retinal macroglia changes in a triple transgenic mouse model of Alzheimer's disease.
    Edwards MM; Rodríguez JJ; Gutierrez-Lanza R; Yates J; Verkhratsky A; Lutty GA
    Exp Eye Res; 2014 Oct; 127():252-60. PubMed ID: 25149907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultrasound with microbubbles improves memory, ameliorates pathology and modulates hippocampal proteomic changes in a triple transgenic mouse model of Alzheimer's disease.
    Shen Y; Hua L; Yeh CK; Shen L; Ying M; Zhang Z; Liu G; Li S; Chen S; Chen X; Yang X
    Theranostics; 2020; 10(25):11794-11819. PubMed ID: 33052247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tau passive immunization inhibits not only tau but also Aβ pathology.
    Dai CL; Tung YC; Liu F; Gong CX; Iqbal K
    Alzheimers Res Ther; 2017 Jan; 9(1):1. PubMed ID: 28073379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phospho-Tau Changes in the Human CA1 During Alzheimer's Disease Progression.
    Regalado-Reyes M; Furcila D; Hernández F; Ávila J; DeFelipe J; León-Espinosa G
    J Alzheimers Dis; 2019; 69(1):277-288. PubMed ID: 30958368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sex Differences in Neuropathology and Cognitive Behavior in APP/PS1/tau Triple-Transgenic Mouse Model of Alzheimer's Disease.
    Yang JT; Wang ZJ; Cai HY; Yuan L; Hu MM; Wu MN; Qi JS
    Neurosci Bull; 2018 Oct; 34(5):736-746. PubMed ID: 30099679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IVIg protects the 3xTg-AD mouse model of Alzheimer's disease from memory deficit and Aβ pathology.
    St-Amour I; Paré I; Tremblay C; Coulombe K; Bazin R; Calon F
    J Neuroinflammation; 2014 Mar; 11():54. PubMed ID: 24655894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of the receptor for advanced glycation end products in neurons and astrocytes in a triple transgenic mouse model of Alzheimer's disease.
    Choi BR; Cho WH; Kim J; Lee HJ; Chung C; Jeon WK; Han JS
    Exp Mol Med; 2014 Feb; 46(2):e75. PubMed ID: 24503708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A{beta} accelerates the spatiotemporal progression of tau pathology and augments tau amyloidosis in an Alzheimer mouse model.
    Hurtado DE; Molina-Porcel L; Iba M; Aboagye AK; Paul SM; Trojanowski JQ; Lee VM
    Am J Pathol; 2010 Oct; 177(4):1977-88. PubMed ID: 20802182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endogenous murine tau promotes neurofibrillary tangles in 3xTg-AD mice without affecting cognition.
    Baglietto-Vargas D; Kitazawa M; Le EJ; Estrada-Hernandez T; Rodriguez-Ortiz CJ; Medeiros R; Green KN; LaFerla FM
    Neurobiol Dis; 2014 Feb; 62():407-15. PubMed ID: 24176788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid accelerates tau propagation and toxicity in a model of early Alzheimer's disease.
    Pooler AM; Polydoro M; Maury EA; Nicholls SB; Reddy SM; Wegmann S; William C; Saqran L; Cagsal-Getkin O; Pitstick R; Beier DR; Carlson GA; Spires-Jones TL; Hyman BT
    Acta Neuropathol Commun; 2015 Mar; 3():14. PubMed ID: 25853174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial effect of human anti-amyloid-beta active immunization on neurite morphology and tau pathology.
    Serrano-Pozo A; William CM; Ferrer I; Uro-Coste E; Delisle MB; Maurage CA; Hock C; Nitsch RM; Masliah E; Growdon JH; Frosch MP; Hyman BT
    Brain; 2010 May; 133(Pt 5):1312-27. PubMed ID: 20360050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High tryptophan diet reduces CA1 intraneuronal β-amyloid in the triple transgenic mouse model of Alzheimer's disease.
    Noristani HN; Verkhratsky A; Rodríguez JJ
    Aging Cell; 2012 Oct; 11(5):810-22. PubMed ID: 22702392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant expression of the pore-forming K
    Griffith CM; Xie MX; Qiu WY; Sharp AA; Ma C; Pan A; Yan XX; Patrylo PR
    Neuroscience; 2016 Nov; 336():81-101. PubMed ID: 27586053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of nonphosphorylated neurofilament immunoreactivity in temporal cortical areas in Alzheimer's disease.
    Thangavel R; Sahu SK; Van Hoesen GW; Zaheer A
    Neuroscience; 2009 May; 160(2):427-33. PubMed ID: 19250962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrillar Amyloid-β Accumulation Triggers an Inflammatory Mechanism Leading to Hyperphosphorylation of the Carboxyl-Terminal End of Tau Polypeptide in the Hippocampal Formation of the 3×Tg-AD Transgenic Mouse.
    Ontiveros-Torres MÁ; Labra-Barrios ML; Díaz-Cintra S; Aguilar-Vázquez AR; Moreno-Campuzano S; Flores-Rodríguez P; Luna-Herrera C; Mena R; Perry G; Florán-Garduño B; Luna-Muñoz J; Luna-Arias JP
    J Alzheimers Dis; 2016 Mar; 52(1):243-69. PubMed ID: 27031470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.